ARTICLE | Clinical News
Gammagard Liquid 10% regulatory update
August 1, 2011 7:00 AM UTC
FDA approved an sBLA from Baxter for the subcutaneous administration of Gammagard Liquid 10% to treat primary immunodeficiency. The IV formulation of the IgG antibodies plasma-based therapy is already...